Interim analysis of efficacy and safety of adjuvant donafenib plus transarterial chemoembolization in patients with hepatocellular carcinoma and high-risk features after curative resection.
Authors
Xueshuai Wan (ORCID: https://orcid.org/0000-0003-2140-5384)
Yonghui Ma (ORCID: https://orcid.org/0000-0001-5787-8445)
B L Zhang
Xiaokun Chen
Shunda Du (ORCID: https://orcid.org/0000-0002-0386-9911)
Yongchang Zheng
Xiao Liu
Yilei Mao
Mei Guan
Bao Jin
Kang Zhou
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Interim analysis of efficacy and safety of adjuvant donafenib plus transarterial chemoembolization in patients with hepatocellular carcinoma and high-risk features after curative resection.
Xueshuai Wan, Yonghui Ma, B L Zhang, Xiaokun Chen et al.
Journal
Journal of Clinical Oncology
Topics
Hepatocellular Carcinoma Treatment and Prognosis
article
Interim analysis of efficacy and safety of adjuvant donafenib plus transarterial chemoembolization in patients with hepatocellular carcinoma and high-risk features after curative resection.
Xueshuai Wan, Yonghui Ma, B L Zhang, Xiaokun Chen, Shunda Du, Yongchang Zheng, Xiao Liu, Yilei Mao, Mei Guan, Bao Jin, Kang Zhou
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 44(16_suppl)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN)